SurModics Performance

SRDXDelisted Stock  USD 42.98  0.00  0.00%   
The entity has a beta of -0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning SurModics are expected to decrease at a much lower rate. During the bear market, SurModics is likely to outperform the market. SurModics right now has a risk of 0.0%. Please validate SurModics total risk alpha, downside variance, as well as the relationship between the Downside Variance and day median price , to decide if SurModics will be following its existing price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days SurModics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, SurModics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow41.4 M
Total Cashflows From Investing Activities-2.9 M
  

SurModics Relative Risk vs. Return Landscape

If you would invest  4,298  in SurModics on November 19, 2025 and sell it today you would earn a total of  0.00  from holding SurModics or generate 0.0% return on investment over 90 days. SurModics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than SurModics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

SurModics Target Price Odds to finish over Current Price

The tendency of SurModics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 42.98 90 days 42.98 
roughly 2.65
Based on a normal probability distribution, the odds of SurModics to move above the current price in 90 days from now is roughly 2.65 (This SurModics probability density function shows the probability of SurModics Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days SurModics has a beta of -0.24. This usually implies as returns on the benchmark increase, returns on holding SurModics are expected to decrease at a much lower rate. During a bear market, however, SurModics is likely to outperform the market. Additionally SurModics has an alpha of 0.5053, implying that it can generate a 0.51 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   SurModics Price Density   
       Price  

Predictive Modules for SurModics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SurModics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SurModics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
42.9842.9842.98
Details
Intrinsic
Valuation
LowRealHigh
33.0133.0147.28
Details

SurModics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. SurModics is not an exception. The market had few large corrections towards the SurModics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SurModics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SurModics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.51
β
Beta against Dow Jones-0.24
σ
Overall volatility
5.48
Ir
Information ratio 0.07

SurModics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SurModics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SurModics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
SurModics is not yet fully synchronised with the market data
SurModics generated a negative expected return over the last 90 days
SurModics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 92.07 M.
Over 87.0% of the company shares are owned by institutional investors

SurModics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of SurModics Stock often depends not only on the future outlook of the current and potential SurModics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SurModics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.2 M
Cash And Short Term Investments40.1 M

SurModics Fundamentals Growth

SurModics Stock prices reflect investors' perceptions of the future prospects and financial health of SurModics, and SurModics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SurModics Stock performance.

About SurModics Performance

Evaluating SurModics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if SurModics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SurModics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.

Things to note about SurModics performance evaluation

Checking the ongoing alerts about SurModics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SurModics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
SurModics is not yet fully synchronised with the market data
SurModics generated a negative expected return over the last 90 days
SurModics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 92.07 M.
Over 87.0% of the company shares are owned by institutional investors
Evaluating SurModics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate SurModics' stock performance include:
  • Analyzing SurModics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SurModics' stock is overvalued or undervalued compared to its peers.
  • Examining SurModics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating SurModics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of SurModics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of SurModics' stock. These opinions can provide insight into SurModics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating SurModics' stock performance is not an exact science, and many factors can impact SurModics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in SurModics Stock

If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance